CRISPR: how to unlock the genetic technology's potential

CRISPR:如何开启基因技术的潜能

Editor's Picks from The Economist

新闻

2025-03-06

5 分钟
PDF

单集简介 ...

A handpicked article read aloud from the latest issue of The Economist. CRISPR, a tool for genetic editing, holds immense promise for medicine and agriculture. But getting the most out of it will require new science and a better system of regulation. Listen to what matters most, from global politics and business to science and technology—subscribe to Economist Podcasts+. For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.
更多

单集文稿 ...

  • The Economist. Hello, this is Alok Jha,

  • host of Babbage, our weekly podcast on science and technology.

  • Welcome to Editor's Picks.

  • We've chosen an unmissable article from the latest edition of The Economist.

  • Please do have a listen.

  • Of the many patients who need an organ from a donor, 90% go without.

  • About 240 million people live with rare genetic diseases, most of which cannot be treated.

  • Each year, poor diets cause more than 10 million early deaths.

  • Suffering on such an immense scale can appear hopeless.

  • However,

  • a technique called CRISPR gene editing promises to help deal with these issues and many more,

  • and wise regulation can spur it on.

  • CRISPR is like an editor that can rewrite DNA letter by letter or gene by gene to remove harmful mutations or add protective ones.

  • Clinical trials will begin this summer on pig organs edited for transplanting into humans.

  • Last year the first new therapy went on the market.

  • It seemingly cures sickle cell disease and beta thalassemia,

  • two blood disorders that afflict millions.

  • If ongoing clinical trials succeed,

  • a one-off therapy could provide lifelong protection against heart attacks.

  • Farming will benefit too.